Table 7 Butyrylcholinesterase inhibitor activity results.

From: Development of donepezil hydrochloride-loaded PLGA-based nanoparticles for Alzheimer’s disease treatment

Code

Inhibition (%)

 

400 µg mL− 1

200 µg mL− 1

100 µg/mL− 1

IC50 (µg mL− 1)

I-DNP

82.96 ± 0.57

76.35 ± 0.7

71.04 ± 0.69

36.75

I-Blank

–

–

–

–

DNP

89.50 ± 0.04

78.55 ± 0.08

63.03 ± 0.02

43.07

Back to article page